{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:38:00Z","timestamp":1794494280602,"version":"4.9.1"},"reference-count":240,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Chem"],"DOI":"10.1038\/s41570-026-00865-0","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:21:27Z","timestamp":1789125687000},"page":"702-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Structural evolution of ionizable lipids for nucleic acid delivery"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-1336","authenticated-orcid":false,"given":"Lulu","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melgious Jin Yan","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-9206","authenticated-orcid":false,"given":"Kelsey L.","family":"Swingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1157-4960","authenticated-orcid":false,"given":"Emily","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0256-3862","authenticated-orcid":false,"given":"Ori","family":"Chalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0047-337X","authenticated-orcid":false,"given":"Ning","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2244","authenticated-orcid":false,"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"865_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrd837","volume":"1","author":"JB Opalinska","year":"2002","unstructured":"Opalinska, J. B. & Gewirtz, A. M. Nucleic-acid therapeutics: basic principles and recent applications. Nat. Rev. Drug. Discov. 1, 503\u2013514 (2002).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"865_CR2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni, J. A. et al. The current landscape of nucleic acid therapeutics. Nat. Nanotechnol. 16, 630\u2013643 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nri3875","volume":"15","author":"T Junt","year":"2015","unstructured":"Junt, T. & Barchet, W. Translating nucleic acid-sensing pathways into therapies. Nat. Rev. Immunol. 15, 529\u2013544 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"865_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes, B. B. et al. Nanodelivery of nucleic acids. Nat. Rev. Methods Primer 2, 24 (2022).","journal-title":"Nat. Rev. Methods Primer"},{"key":"865_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/bcp.12987","volume":"82","author":"K Sridharan","year":"2016","unstructured":"Sridharan, K. & Gogtay, N. J. Therapeutic nucleic acids: current clinical status. Br. J. Clin. Pharmacol. 82, 659\u2013672 (2016).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"865_CR6","doi-asserted-by":"publisher","first-page":"10469","DOI":"10.1021\/acs.chemrev.1c00241","volume":"121","author":"M Li","year":"2021","unstructured":"Li, M. et al. Nucleic acid tests for clinical translation. Chem. Rev. 121, 10469\u201310558 (2021).","journal-title":"Chem. Rev."},{"key":"865_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/nat.2021.0085","volume":"32","author":"DR Corey","year":"2022","unstructured":"Corey, D. R., Damha, M. J. & Manoharan, M. Challenges and opportunities for nucleic acid therapeutics. Nucleic Acid. Ther. 32, 8\u201313 (2022).","journal-title":"Nucleic Acid. Ther."},{"key":"865_CR8","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1182\/blood.V92.3.712","volume":"92","author":"AM Gewirtz","year":"1998","unstructured":"Gewirtz, A. M., Sokol, D. L. & Ratajczak, M. Z. Nucleic acid therapeutics: state of the art and future prospects. Blood 92, 712\u2013736 (1998).","journal-title":"Blood"},{"key":"865_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1021\/acs.accounts.2c00464","volume":"56","author":"M Lu","year":"2023","unstructured":"Lu, M., Xing, H., Zheng, A., Huang, Y. & Liang, X.-J. Overcoming pharmaceutical bottlenecks for nucleic acid drug development. Acc. Chem. Res. 56, 224\u2013236 (2023).","journal-title":"Acc. Chem. Res."},{"key":"865_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1809","volume":"14","author":"LM Moll\u00e9","year":"2022","unstructured":"Moll\u00e9, L. M., Smyth, C. H., Yuen, D. & Johnston, A. P. R. Nanoparticles for vaccine and gene therapy: overcoming the barriers to nucleic acid delivery. WIREs Nanomed. Nanobiotechnol. 14, e1809 (2022).","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"865_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1039\/D3CS00194F","volume":"53","author":"H Zhang","year":"2024","unstructured":"Zhang, H., Vandesompele, J., Braeckmans, K., De Smedt, S. C. & Remaut, K. Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity. Chem. Soc. Rev. 53, 317\u2013360 (2024).","journal-title":"Chem. Soc. Rev."},{"key":"865_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.omtn.2019.12.004","volume":"19","author":"Y Weng","year":"2020","unstructured":"Weng, Y. et al. Improved nucleic acid therapy with advanced nanoscale biotechnology. Mol. Ther. Nucleic Acids 19, 581\u2013601 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"865_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10213","volume":"6","author":"M Schlich","year":"2021","unstructured":"Schlich, M. et al. Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles. Bioeng. Transl. Med. 6, e10213 (2021).","journal-title":"Bioeng. Transl. Med."},{"key":"865_CR14","doi-asserted-by":"publisher","first-page":"11527","DOI":"10.1021\/acs.chemrev.0c00997","volume":"121","author":"R Kumar","year":"2021","unstructured":"Kumar, R. et al. Polymeric delivery of therapeutic nucleic acids. Chem. Rev. 121, 11527\u201311652 (2021).","journal-title":"Chem. Rev."},{"key":"865_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","volume":"23","author":"PR Cullis","year":"2024","unstructured":"Cullis, P. R. & Felgner, P. L. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat. Rev. Drug. Discov. 23, 709\u2013722 (2024).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"865_CR16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1021\/ar3000162","volume":"45","author":"J Nguyen","year":"2012","unstructured":"Nguyen, J. & Szoka, F. C. Nucleic acid delivery: the missing pieces of the puzzle? Acc. Chem. Res. 45, 1153\u20131162 (2012).","journal-title":"Acc. Chem. Res."},{"key":"865_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.copbio.2004.10.005","volume":"15","author":"D Felnerova","year":"2004","unstructured":"Felnerova, D., Viret, J.-F., Gl\u00fcck, R. & Moser, C. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr. Opin. Biotechnol. 15, 518\u2013529 (2004).","journal-title":"Curr. Opin. Biotechnol."},{"key":"865_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","volume":"40","author":"D Sun","year":"2023","unstructured":"Sun, D. & Lu, Z.-R. Structure and function of cationic and ionizable lipids for nucleic acid delivery. Pharm. Res. 40, 27\u201346 (2023).","journal-title":"Pharm. Res."},{"key":"865_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1359-0294(00)00091-1","volume":"6","author":"MC Woodle","year":"2001","unstructured":"Woodle, M. C. & Scaria, P. Cationic liposomes and nucleic acids. Curr. Opin. Colloid Interface Sci. 6, 78\u201384 (2001).","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"865_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chemphyslip.2010.01.001","volume":"163","author":"NM Rao","year":"2010","unstructured":"Rao, N. M. Cationic lipid-mediated nucleic acid delivery: beyond being cationic. Chem. Phys. Lipids 163, 245\u2013252 (2010).","journal-title":"Chem. Phys. Lipids"},{"key":"865_CR21","doi-asserted-by":"publisher","first-page":"12573","DOI":"10.1021\/bi00208a007","volume":"33","author":"AL Bailey","year":"1994","unstructured":"Bailey, A. L. & Cullis, P. R. Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. Biochemistry 33, 12573\u201312580 (1994).","journal-title":"Biochemistry"},{"key":"865_CR22","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis, P. R. & Hope, M. J. Lipid nanoparticle systems for enabling gene therapies. Mol. Ther. 25, 1467\u20131475 (2017).","journal-title":"Mol. Ther."},{"key":"865_CR23","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","volume":"54","author":"C Wang","year":"2021","unstructured":"Wang, C., Zhang, Y. & Dong, Y. Lipid nanoparticle\u2013mRNA formulations for therapeutic applications. Acc. Chem. Res. 54, 4283\u20134293 (2021).","journal-title":"Acc. Chem. Res."},{"key":"865_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"865_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s13346-013-0161-z","volume":"4","author":"C Wan","year":"2014","unstructured":"Wan, C., Allen, T. M. & Cullis, P. R. Lipid nanoparticle delivery systems for siRNA-based therapeutics. Drug. Deliv. Transl. Res. 4, 74\u201383 (2014).","journal-title":"Drug. Deliv. Transl. Res."},{"key":"865_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/10600280241301432","volume":"59","author":"Z Anfaal","year":"2025","unstructured":"Anfaal, Z., Khan, Z. A. & Aslam, M. A. FDA approves mRESVIA: embracing the new era of RSV prevention with advanced mRNA technology. Ann. Pharmacother. 59, 676\u2013677 (2025).","journal-title":"Ann. Pharmacother."},{"key":"865_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084\u20131087 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR28","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov, R., Bird, R., Curtze, A. E. & Zhou, Q. Lipid nanoparticles \u2014 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15, 16982\u201317015 (2021).","journal-title":"ACS Nano"},{"key":"865_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/d41573-023-00002-2","volume":"22","author":"M Verma","year":"2023","unstructured":"Verma, M. et al. The landscape for lipid-nanoparticle-based genomic medicines. Nat. Rev. Drug. Discov. 22, 349\u2013350 (2023).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"865_CR30","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int. J. Pharm. 601, 120586 (2021).","journal-title":"Int. J. Pharm."},{"key":"865_CR31","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","volume":"52","author":"JA Kulkarni","year":"2019","unstructured":"Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R. & Van Der Meel, R. Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Acc. Chem. Res. 52, 2435\u20132444 (2019).","journal-title":"Acc. Chem. Res."},{"key":"865_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. Acc. Chem. Res. 55, 2\u201312 (2022).","journal-title":"Acc. Chem. Res."},{"key":"865_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","volume":"159","author":"D Witzigmann","year":"2020","unstructured":"Witzigmann, D. et al. Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv. Drug. Deliv. Rev. 159, 344\u2013363 (2020).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"865_CR34","doi-asserted-by":"publisher","first-page":"2500383","DOI":"10.1002\/adhm.202500383","volume":"14","author":"BI Hanafy","year":"2025","unstructured":"Hanafy, B. I. et al. Advancing cellular-specific delivery: machine learning insights into lipid nanoparticles design and cellular tropism. Adv. Healthc. Mater. 14, 2500383 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"865_CR35","doi-asserted-by":"publisher","first-page":"2303261","DOI":"10.1002\/adma.202303261","volume":"35","author":"Y Zong","year":"2023","unstructured":"Zong, Y., Lin, Y., Wei, T. & Cheng, Q. Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv. Mater. 35, 2303261 (2023).","journal-title":"Adv. Mater."},{"key":"865_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","volume":"20","author":"E Kon","year":"2023","unstructured":"Kon, E., Ad-El, N., Hazan-Halevy, I., Stotsky-Oterin, L. & Peer, D. Targeting cancer with mRNA\u2013lipid nanoparticles: key considerations and future prospects. Nat. Rev. Clin. Oncol. 20, 739\u2013754 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"865_CR37","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1021\/acs.nanolett.0c01386","volume":"20","author":"Y Eygeris","year":"2020","unstructured":"Eygeris, Y., Patel, S., Jozic, A. & Sahay, G. Deconvoluting lipid nanoparticle structure for messenger RNA delivery. Nano Lett. 20, 4543\u20134549 (2020).","journal-title":"Nano Lett."},{"key":"865_CR38","doi-asserted-by":"publisher","first-page":"2100109","DOI":"10.1002\/anbr.202100109","volume":"2","author":"L Xu","year":"2022","unstructured":"Xu, L. et al. Lipid nanoparticles for drug delivery. Adv. NanoBiomed Res. 2, 2100109 (2022).","journal-title":"Adv. NanoBiomed Res."},{"key":"865_CR39","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.jpha.2024.100996","volume":"14","author":"R Maharjan","year":"2024","unstructured":"Maharjan, R., Kim, K. H., Lee, K., Han, H.-K. & Jeong, S. H. Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost\/Bayesian method and ensemble model approaches. J. Pharm. Anal. 14, 100996 (2024).","journal-title":"J. Pharm. Anal."},{"key":"865_CR40","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/pharmaceutics13101675","volume":"13","author":"MM \u017bak","year":"2021","unstructured":"\u017bak, M. M. & Zangi, L. Lipid nanoparticles for organ-specific mRNA therapeutic delivery. Pharmaceutics 13, 1675 (2021).","journal-title":"Pharmaceutics"},{"key":"865_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202501401","volume":"9","author":"C Kim","year":"2025","unstructured":"Kim, C., Lee, Y., Lee, H. & Kim, B. Advances in mRNA-lipid nanoparticle engineering for immune cell targeting and immune modulation. Small Methods 9, e01401 (2025).","journal-title":"Small Methods"},{"key":"865_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","volume":"3","author":"KE Lindsay","year":"2019","unstructured":"Lindsay, K. E. et al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET\u2013CT and near-infrared imaging. Nat. Biomed. Eng. 3, 371\u2013380 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"865_CR43","doi-asserted-by":"publisher","first-page":"5c01272","DOI":"10.1021\/acs.biomac.5c01272","volume":"26","author":"X Xiao","year":"2025","unstructured":"Xiao, X. et al. Impact of stimuli-responsiveness on the mRNA delivery efficiency of low-generation dendrimer nanogels. Biomacromolecules 26, 5c01272 (2025).","journal-title":"Biomacromolecules"},{"key":"865_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han, X. et al. An ionizable lipid toolbox for RNA delivery. Nat. Commun. 12, 7233 (2021).","journal-title":"Nat. Commun."},{"key":"865_CR45","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1039\/D3TB00649B","volume":"11","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Golubovic, A., Xu, S., Pan, A. & Li, B. Rational design and combinatorial chemistry of ionizable lipids for RNA delivery. J. Mater. Chem. B 11, 6527\u20136539 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"865_CR46","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1021\/acs.accounts.1c00500","volume":"54","author":"M Qiu","year":"2021","unstructured":"Qiu, M., Li, Y., Bloomer, H. & Xu, Q. Developing biodegradable lipid nanoparticles for intracellular mRNA delivery and genome editing. Acc. Chem. Res. 54, 4001\u20134011 (2021).","journal-title":"Acc. Chem. Res."},{"key":"865_CR47","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.1021\/acsnano.7b04734","volume":"11","author":"S Rietwyk","year":"2017","unstructured":"Rietwyk, S. & Peer, D. Next-generation lipids in RNA interference therapeutics. ACS Nano 11, 7572\u20137586 (2017).","journal-title":"ACS Nano"},{"key":"865_CR48","doi-asserted-by":"publisher","first-page":"121596","DOI":"10.1016\/j.ijpharm.2022.121596","volume":"617","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Structure\u2013activity relationships of pH-responsive and ionizable lipids for gene delivery. Int. J. Pharm. 617, 121596 (2022).","journal-title":"Int. J. Pharm."},{"key":"865_CR49","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1021\/acsbiomaterials.5c00463","volume":"11","author":"SM Lee","year":"2025","unstructured":"Lee, S. M. et al. Structure\u2013activity relationship of ionizable lipids for siRNA and mRNA lipid nanoparticle design. ACS Biomater. Sci. Eng. 11, 4844\u20134852 (2025).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"865_CR50","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","volume":"121","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Sun, C., Wang, C., Jankovic, K. E. & Dong, Y. Lipids and lipid derivatives for RNA delivery. Chem. Rev. 121, 12181\u201312277 (2021).","journal-title":"Chem. Rev."},{"key":"865_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/10611869609015970","volume":"4","author":"P Tardi","year":"1996","unstructured":"Tardi, P., Boman, N. & Cullis, P. Liposomal doxorubicin. J. Drug. Target. 4, 129\u2013140 (1996).","journal-title":"J. Drug. Target."},{"key":"865_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0304-4157(93)90004-8","volume":"1154","author":"JG Smith","year":"1993","unstructured":"Smith, J. G., Walzem, R. L. & Bruce German, J. Liposomes as agents of DNA transfer. Biochim. Biophys. Acta Rev. Biomembr. 1154, 327\u2013340 (1993).","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"key":"865_CR53","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","volume":"86","author":"RW Malone","year":"1989","unstructured":"Malone, R. W., Felgner, P. L. & Verma, I. M. Cationic liposome-mediated RNA transfection. Proc. Natl Acad. Sci. USA 86, 6077\u20136081 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jconrel.2004.08.019","volume":"100","author":"S Zhang","year":"2004","unstructured":"Zhang, S. et al. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J. Controlled Rel. 100, 165\u2013180 (2004).","journal-title":"J. Controlled Rel."},{"key":"865_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/326497","volume":"2011","author":"DA Balazs","year":"2011","unstructured":"Balazs, D. A. & Godbey, W. Liposomes for use in gene delivery. J. Drug. Deliv. 2011, 1\u201312 (2011).","journal-title":"J. Drug. Deliv."},{"key":"865_CR56","doi-asserted-by":"publisher","first-page":"11043","DOI":"10.1021\/cr5006793","volume":"115","author":"U L\u00e4chelt","year":"2015","unstructured":"L\u00e4chelt, U. & Wagner, E. Nucleic acid therapeutics using polyplexes: a journey of 50 years (and beyond). Chem. Rev. 115, 11043\u201311078 (2015).","journal-title":"Chem. Rev."},{"key":"865_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijpharm.2008.07.010","volume":"363","author":"M Matsumoto","year":"2008","unstructured":"Matsumoto, M. et al. Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery. Int. J. Pharm. 363, 58\u201365 (2008).","journal-title":"Int. J. Pharm."},{"key":"865_CR58","doi-asserted-by":"publisher","first-page":"212984","DOI":"10.1016\/j.bioadv.2022.212984","volume":"139","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. pH-sensitive, tail-modified, ester-linked ionizable cationic lipids for gene delivery. Biomater. Adv. 139, 212984 (2022).","journal-title":"Biomater. Adv."},{"key":"865_CR59","doi-asserted-by":"publisher","first-page":"2100683","DOI":"10.1002\/marc.202100683","volume":"43","author":"G Settanni","year":"2022","unstructured":"Settanni, G., Brill, W., Haas, H. & Schmid, F. pH-dependent behavior of ionizable cationic lipids in mRNA-carrying lipoplexes investigated by molecular dynamics simulations. Macromol. Rapid Commun. 43, 2100683 (2022).","journal-title":"Macromol. Rapid Commun."},{"key":"865_CR60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310491120","volume":"120","author":"J Philipp","year":"2023","unstructured":"Philipp, J. et al. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function. Proc. Natl Acad. Sci. USA 120, e2310491120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR61","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/pharmaceutics17101309","volume":"17","author":"Y Kim","year":"2025","unstructured":"Kim, Y. et al. Physiological barriers to nucleic acid therapeutics and engineering strategies for lipid nanoparticle design, optimization, and clinical translation. Pharmaceutics 17, 1309 (2025).","journal-title":"Pharmaceutics"},{"key":"865_CR62","doi-asserted-by":"publisher","first-page":"40293","DOI":"10.1021\/acsnano.5c11721","volume":"19","author":"D Pei","year":"2025","unstructured":"Pei, D. Endosomal escape of lipid nanoparticles: a perspective on the literature data. ACS Nano 19, 40293\u201340303 (2025).","journal-title":"ACS Nano"},{"key":"865_CR63","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638\u2013646 (2013).","journal-title":"Nat. Biotechnol."},{"key":"865_CR64","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nbt.3298","volume":"33","author":"A Wittrup","year":"2015","unstructured":"Wittrup, A. et al. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat. Biotechnol. 33, 870\u2013876 (2015).","journal-title":"Nat. Biotechnol."},{"key":"865_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60959-z","volume":"16","author":"JM Johansson","year":"2025","unstructured":"Johansson, J. M. et al. Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol. Nat. Commun. 16, 5354 (2025).","journal-title":"Nat. Commun."},{"key":"865_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400199","volume":"19","author":"Z He","year":"2024","unstructured":"He, Z., Liu, Z. & Chen, Y. Chemical design strategy of ionizable lipids for in vivo mRNA delivery. ChemMedChem 19, e202400199 (2024).","journal-title":"ChemMedChem"},{"key":"865_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","volume":"99","author":"X Cheng","year":"2016","unstructured":"Cheng, X. & Lee, R. J. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Adv. Drug. Deliv. Rev. 99, 129\u2013137 (2016).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"865_CR68","doi-asserted-by":"publisher","first-page":"2300006","DOI":"10.1002\/anbr.202300006","volume":"3","author":"X Tang","year":"2023","unstructured":"Tang, X., Zhang, Y. & Han, X. Ionizable lipid nanoparticles for mRNA delivery. Adv. NanoBiomed Res. 3, 2300006 (2023).","journal-title":"Adv. NanoBiomed Res."},{"key":"865_CR69","doi-asserted-by":"publisher","first-page":"115446","DOI":"10.1016\/j.addr.2024.115446","volume":"214","author":"K Mrksich","year":"2024","unstructured":"Mrksich, K., Padilla, M. S. & Mitchell, M. J. Breaking the final barrier: evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome. Adv. Drug. Deliv. Rev. 214, 115446 (2024).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"865_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijpharm.2016.06.124","volume":"510","author":"Y Suzuki","year":"2016","unstructured":"Suzuki, Y. & Ishihara, H. Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid. Int. J. Pharm. 510, 350\u2013358 (2016).","journal-title":"Int. J. Pharm."},{"key":"865_CR71","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","volume":"12","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni, J. A. et al. On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano 12, 4787\u20134795 (2018).","journal-title":"ACS Nano"},{"key":"865_CR72","doi-asserted-by":"publisher","first-page":"28012","DOI":"10.1021\/acsami.5c06464","volume":"17","author":"JE Shin","year":"2025","unstructured":"Shin, J. E. et al. Transition temperature-guided design of lipid nanoparticles for effective mRNA delivery. ACS Appl. Mater. Interfaces 17, 28012\u201328024 (2025).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"865_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10580","volume":"8","author":"MM Lewis","year":"2023","unstructured":"Lewis, M. M. et al. Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles. Bioeng. Transl. Med. 8, e10580 (2023).","journal-title":"Bioeng. Transl. Med."},{"key":"865_CR74","doi-asserted-by":"publisher","first-page":"2209624","DOI":"10.1002\/adma.202209624","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam, K. et al. Unsaturated, trialkyl ionizable lipids are versatile lipid-nanoparticle components for therapeutic and vaccine applications. Adv. Mater. 35, 2209624 (2023).","journal-title":"Adv. Mater."},{"key":"865_CR75","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nbt1402","volume":"26","author":"A Akinc","year":"2008","unstructured":"Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26, 561\u2013569 (2008).","journal-title":"Nat. Biotechnol."},{"key":"865_CR76","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28, 172\u2013176 (2010).","journal-title":"Nat. Biotechnol."},{"key":"865_CR77","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.0910603106","volume":"107","author":"KT Love","year":"2010","unstructured":"Love, K. T. et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl Acad. Sci. USA 107, 1864\u20131869 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41427-025-00595-7","volume":"17","author":"Z He","year":"2025","unstructured":"He, Z., Le, Z., Liu, Z. & Chen, Y. Multicomponent reaction-based combinatorial chemistry for accelerating the discovery of therapeutic protein and nucleic acid delivery materials. NPG Asia Mater. 17, 14 (2025).","journal-title":"NPG Asia Mater."},{"key":"865_CR79","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","volume":"37","author":"L Miao","year":"2019","unstructured":"Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174\u20131185 (2019).","journal-title":"Nat. Biotechnol."},{"key":"865_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202310401","volume":"135","author":"Z He","year":"2023","unstructured":"He, Z. et al. A multidimensional approach to modulating ionizable lipids for high-performing and organ-selective mRNA delivery. Angew. Chem. Int. Ed. 135, e202310401 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"865_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59136-z","volume":"16","author":"KY Vlasova","year":"2025","unstructured":"Vlasova, K. Y. et al. Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing. Nat. Commun. 16, 4021 (2025).","journal-title":"Nat. Commun."},{"key":"865_CR82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409572122","volume":"122","author":"Y Xu","year":"2025","unstructured":"Xu, Y. et al. Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery. Proc. Natl Acad. Sci. USA 122, e2409572122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR83","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/s41551-025-01422-8","volume":"9","author":"N Gong","year":"2025","unstructured":"Gong, N. et al. Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity. Nat. Biomed. Eng. 9, 2181\u20132195 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"865_CR84","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41557-024-01557-2","volume":"16","author":"X Han","year":"2024","unstructured":"Han, X. et al. Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo. Nat. Chem. 16, 1687\u20131697 (2024).","journal-title":"Nat. Chem."},{"key":"865_CR85","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41551-024-01267-7","volume":"8","author":"X Han","year":"2024","unstructured":"Han, X. et al. Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution. Nat. Biomed. Eng. 8, 1412\u20131424 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"865_CR86","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1073\/pnas.1322937111","volume":"111","author":"Y Dong","year":"2014","unstructured":"Dong, Y. et al. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl Acad. Sci. USA 111, 3955\u20133960 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114030","volume":"385","author":"K Miyasaki","year":"2025","unstructured":"Miyasaki, K. et al. Formulation methods for peptide-modified lipid nanoparticles. J. Controlled Rel. 385, 114030 (2025).","journal-title":"J. Controlled Rel."},{"key":"865_CR88","doi-asserted-by":"publisher","first-page":"25397","DOI":"10.1039\/D2RA02771B","volume":"12","author":"J Qin","year":"2022","unstructured":"Qin, J. et al. RGD peptide-based lipids for targeted mRNA delivery and gene editing applications. RSC Adv. 12, 25397\u201325404 (2022).","journal-title":"RSC Adv."},{"key":"865_CR89","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41563-025-02320-9","volume":"25","author":"Y Lin","year":"2025","unstructured":"Lin, Y. et al. Tissue-specific mRNA delivery and prime editing with peptide\u2013ionizable lipid nanoparticles. Nat. Mater. 25, 133\u2013145 (2025).","journal-title":"Nat. Mater."},{"key":"865_CR90","doi-asserted-by":"publisher","first-page":"2400307","DOI":"10.1002\/adma.202400307","volume":"36","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. Tumor-tailored ionizable lipid nanoparticles facilitate IL-12 circular RNA delivery for enhanced lung cancer immunotherapy. Adv. Mater. 36, 2400307 (2024).","journal-title":"Adv. Mater."},{"key":"865_CR91","doi-asserted-by":"publisher","first-page":"2200071","DOI":"10.1002\/smsc.202200071","volume":"3","author":"K Hashiba","year":"2023","unstructured":"Hashiba, K. et al. Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. Small Sci. 3, 2200071 (2023).","journal-title":"Small Sci."},{"key":"865_CR92","doi-asserted-by":"publisher","first-page":"34733","DOI":"10.1021\/jacs.4c13154","volume":"146","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. Isosteric 3D bicyclo[1.1.1]pentane (BCP) core-based lipids for mRNA delivery and CRISPR\/Cas gene editing. J. Am. Chem. Soc. 146, 34733\u201334742 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR93","doi-asserted-by":"publisher","first-page":"2303370","DOI":"10.1002\/adma.202303370","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng, M. H. Y. et al. Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv. Mater. 35, 2303370 (2023).","journal-title":"Adv. Mater."},{"key":"865_CR94","doi-asserted-by":"publisher","first-page":"21206","DOI":"10.1021\/acsnano.4c18274","volume":"19","author":"A Udepurkar","year":"2025","unstructured":"Udepurkar, A. et al. Structure and morphology of lipid nanoparticles for nucleic acid drug delivery: a review. ACS Nano 19, 21206\u201321242 (2025).","journal-title":"ACS Nano"},{"key":"865_CR95","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/adhm.201400039","volume":"3","author":"M Wang","year":"2014","unstructured":"Wang, M. et al. Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles. Adv. Healthc. Mater. 3, 1398\u20131403 (2014).","journal-title":"Adv. Healthc. Mater."},{"key":"865_CR96","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","volume":"20","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Mater. 20, 701\u2013710 (2021).","journal-title":"Nat. Mater."},{"key":"865_CR97","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","volume":"20","author":"L Xue","year":"2025","unstructured":"Xue, L. et al. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery. Nat. Nanotechnol. 20, 132\u2013143 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR98","doi-asserted-by":"publisher","first-page":"24302","DOI":"10.1021\/jacs.3c09143","volume":"145","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Modular design of biodegradable ionizable lipids for improved mRNA delivery and precise cancer metastasis delineation in vivo. J. Am. Chem. Soc. 145, 24302\u201324314 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR99","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","volume":"8","author":"N Chaudhary","year":"2024","unstructured":"Chaudhary, N. et al. Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d. Nat. Biomed. Eng. 8, 1483\u20131498 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"865_CR100","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf4398","volume":"7","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Sci. Adv. 7, eabf4398 (2021).","journal-title":"Sci. Adv."},{"key":"865_CR101","doi-asserted-by":"publisher","first-page":"2401445","DOI":"10.1002\/adma.202401445","volume":"36","author":"D Song","year":"2024","unstructured":"Song, D., Zhao, Y., Wang, Z. & Xu, Q. Tuning lipid nanoparticles for RNA delivery to extrahepatic organs. Adv. Mater. 36, 2401445 (2024).","journal-title":"Adv. Mater."},{"key":"865_CR102","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1039\/D2CS00998F","volume":"52","author":"L Fu","year":"2023","unstructured":"Fu, L. et al. \u2018Passive\u2019 nanoparticles for organ-selective systemic delivery: design, mechanism and perspective. Chem. Soc. Rev. 52, 7579\u20137601 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"865_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55137-6","volume":"16","author":"MS Padilla","year":"2025","unstructured":"Padilla, M. S. et al. Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR\u2013Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering. Nat. Commun. 16, 996 (2025).","journal-title":"Nat. Commun."},{"key":"865_CR104","doi-asserted-by":"publisher","first-page":"2501037","DOI":"10.1002\/adhm.202501037","volume":"14","author":"E Samaridou","year":"2025","unstructured":"Samaridou, E., Simon, J., Beck-Broichsitter, M., Davidson, G. & Levkin, P. A. Rational design of unsaturated, thioether ionizable lipids for enhanced in vivo mRNA delivery. Adv. Healthc. Mater. 14, 2501037 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"865_CR105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307813120","volume":"121","author":"Y Eygeris","year":"2024","unstructured":"Eygeris, Y. et al. Thiophene-based lipids for mRNA delivery to pulmonary and retinal tissues. Proc. Natl Acad. Sci. USA 121, e2307813120 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR106","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409266122","volume":"122","author":"VV Shuvaev","year":"2025","unstructured":"Shuvaev, V. V. et al. Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo. Proc. Natl Acad. Sci. USA 122, e2409266122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR107","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1021\/acsnano.4c18636","volume":"19","author":"G Somu Naidu","year":"2025","unstructured":"Somu Naidu, G. et al. Ionizable lipids with optimized linkers enable lung-specific, lipid nanoparticle-mediated mRNA delivery for treatment of metastatic lung tumors. ACS Nano 19, 6571\u20136587 (2025).","journal-title":"ACS Nano"},{"key":"865_CR108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116271119","volume":"119","author":"M Qiu","year":"2022","unstructured":"Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR109","doi-asserted-by":"publisher","first-page":"15085","DOI":"10.1021\/jacs.4c00451","volume":"146","author":"W Dong","year":"2024","unstructured":"Dong, W. et al. Multicomponent synthesis of imidazole-based ionizable lipids for highly efficient and spleen-selective messenger RNA delivery. J. Am. Chem. Soc. 146, 15085\u201315095 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR110","doi-asserted-by":"publisher","first-page":"28665","DOI":"10.1021\/jacs.5c01389","volume":"147","author":"S Wu","year":"2025","unstructured":"Wu, S. et al. Carbonate-bearing ionizable lipids for mRNA delivery to splenic NK cells. J. Am. Chem. Soc. 147, 28665\u201328673 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR111","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1021\/jacs.4c10265","volume":"147","author":"L Xue","year":"2025","unstructured":"Xue, L. et al. Multiarm-assisted design of dendron-like degradable ionizable lipids facilitates systemic mRNA delivery to the spleen. J. Am. Chem. Soc. 147, 1542\u20131552 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR112","doi-asserted-by":"publisher","first-page":"21321","DOI":"10.1021\/jacs.1c09822","volume":"143","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Zwitterionic phospholipidation of cationic polymers facilitates systemic mRNA delivery to spleen and lymph nodes. J. Am. Chem. Soc. 143, 21321\u201321330 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR113","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1039\/D3TB00516J","volume":"11","author":"H Huo","year":"2023","unstructured":"Huo, H. et al. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles. J. Mater. Chem. B 11, 4171\u20134180 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"865_CR114","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR115","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR116","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","volume":"4","author":"MJ Carrasco","year":"2021","unstructured":"Carrasco, M. J. et al. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun. Biol. 4, 956 (2021).","journal-title":"Commun. Biol."},{"key":"865_CR117","doi-asserted-by":"publisher","first-page":"113879","DOI":"10.1016\/j.jconrel.2025.113879","volume":"384","author":"JB Simonsen","year":"2025","unstructured":"Simonsen, J. B. & Larsson, P. A perspective on the apparent pKa of ionizable lipids in mRNA\u2013LNPs. J. Controlled Rel. 384, 113879 (2025).","journal-title":"J. Controlled Rel."},{"key":"865_CR118","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1021\/jacs.2c10670","volume":"145","author":"G Tilstra","year":"2023","unstructured":"Tilstra, G. et al. Iterative design of ionizable lipids for intramuscular mRNA delivery. J. Am. Chem. Soc. 145, 2294\u20132304 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR119","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41586-024-08291-2","volume":"637","author":"KL Swingle","year":"2025","unstructured":"Swingle, K. L. et al. Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia. Nature 637, 412\u2013421 (2025).","journal-title":"Nature"},{"key":"865_CR120","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41551-023-01030-4","volume":"7","author":"LH Rhym","year":"2023","unstructured":"Rhym, L. H., Manan, R. S., Koller, A., Stephanie, G. & Anderson, D. G. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery. Nat. Biomed. Eng. 7, 901\u2013910 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"865_CR121","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s11033-025-11011-2","volume":"52","author":"RF Alzahrani","year":"2025","unstructured":"Alzahrani, R. F. et al. Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1\u03b2, IL-6, BCL2\/BAX gene expression, and GPX4, COX-2, and MMP-9 activities. Mol. Biol. Rep. 52, 926 (2025).","journal-title":"Mol. Biol. Rep."},{"key":"865_CR122","doi-asserted-by":"publisher","first-page":"9926","DOI":"10.1021\/jacs.2c02706","volume":"144","author":"L Xue","year":"2022","unstructured":"Xue, L. et al. Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment. J. Am. Chem. Soc. 144, 9926\u20139937 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202415389","volume":"64","author":"I Yoon","year":"2025","unstructured":"Yoon, I. et al. Piperazine-derived bisphosphonate-based ionizable lipid nanoparticles enhance mRNA delivery to the bone microenvironment. Angew. Chem. Int. Ed. 64, e202415389 (2025).","journal-title":"Angew. Chem. Int. Ed."},{"key":"865_CR124","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb4429","volume":"6","author":"F Ma","year":"2020","unstructured":"Ma, F. et al. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection. Sci. Adv. 6, eabb4429 (2020).","journal-title":"Sci. Adv."},{"key":"865_CR125","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/s41587-024-02487-7","volume":"43","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Intravenous administration of blood\u2013brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system. Nat. Biotechnol. 43, 1783\u20131789 (2025).","journal-title":"Nat. Biotechnol."},{"key":"865_CR126","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1021\/jacs.4c16326","volume":"147","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. Furan-derived lipid nanoparticles for transporting mRNA to the central nervous system. J. Am. Chem. Soc. 147, 16007\u201316017 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR127","doi-asserted-by":"publisher","first-page":"2417097","DOI":"10.1002\/adma.202417097","volume":"37","author":"Y Xue","year":"2025","unstructured":"Xue, Y. et al. Lipid nanoparticles enhance mRNA delivery to the central nervous system upon intrathecal injection. Adv. Mater. 37, 2417097 (2025).","journal-title":"Adv. Mater."},{"key":"865_CR128","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat. Mater. 24, 1653\u20131663 (2025).","journal-title":"Nat. Mater."},{"key":"865_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adw0730","volume":"11","author":"D Cao","year":"2025","unstructured":"Cao, D. et al. Lipid nanoparticles for mRNA delivery in brain via systemic administration. Sci. Adv. 11, eadw0730 (2025).","journal-title":"Sci. Adv."},{"key":"865_CR130","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","volume":"371","author":"HC Geisler","year":"2024","unstructured":"Geisler, H. C. et al. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta. J. Controlled Rel. 371, 455\u2013469 (2024).","journal-title":"J. Controlled Rel."},{"key":"865_CR131","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","volume":"291","author":"H Parhiz","year":"2018","unstructured":"Parhiz, H. et al. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. J. Controlled Rel. 291, 106\u2013115 (2018).","journal-title":"J. Controlled Rel."},{"key":"865_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121339","volume":"281","author":"A Kheirolomoom","year":"2022","unstructured":"Kheirolomoom, A. et al. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift. Biomaterials 281, 121339 (2022).","journal-title":"Biomaterials"},{"key":"865_CR133","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","volume":"29","author":"I Tomb\u00e1cz","year":"2021","unstructured":"Tomb\u00e1cz, I. et al. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA\u2013LNPs. Mol. Ther. 29, 3293\u20133304 (2021).","journal-title":"Mol. Ther."},{"key":"865_CR134","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"865_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2026.115043","volume":"396","author":"J Zeng","year":"2026","unstructured":"Zeng, J. et al. Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering. J. Controlled Rel. 396, 115043 (2026).","journal-title":"J. Controlled Rel."},{"key":"865_CR136","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1126\/science.ads8473","volume":"388","author":"TL Hunter","year":"2025","unstructured":"Hunter, T. L. et al. In vivo CAR T cell generation to treat cancer and autoimmune disease. Science 388, 1311\u20131317 (2025).","journal-title":"Science"},{"key":"865_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06936-1","volume":"9","author":"N Veiga","year":"2018","unstructured":"Veiga, N. et al. Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nat. Commun. 9, 4493 (2018).","journal-title":"Nat. Commun."},{"key":"865_CR138","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/pharmaceutics17080950","volume":"17","author":"W Liu","year":"2025","unstructured":"Liu, W., Zhang, M., Lv, H. & Yang, C. Formulation-driven optimization of PEG-lipid content in lipid nanoparticles for enhanced mRNA delivery in vitro and in vivo. Pharmaceutics 17, 950 (2025).","journal-title":"Pharmaceutics"},{"key":"865_CR139","first-page":"12758","volume":"24","author":"K Hashiba","year":"2024","unstructured":"Hashiba, K. et al. Impact of lipid tail length on the organ selectivity of mRNA-lipid nanoparticles. Nano Lett. 24, 12758 (2024).","journal-title":"Nano Lett."},{"key":"865_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50093-7","volume":"15","author":"K Su","year":"2024","unstructured":"Su, K. et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat. Commun. 15, 5659 (2024).","journal-title":"Nat. Commun."},{"key":"865_CR141","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ady6460","volume":"11","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y. et al. Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation. Sci. Adv. 11, eady6460 (2025).","journal-title":"Sci. Adv."},{"key":"865_CR142","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejpb.2023.10.006","volume":"192","author":"DM Strelkova Petersen","year":"2023","unstructured":"Strelkova Petersen, D. M., Chaudhary, N., Arral, M. L., Weiss, R. M. & Whitehead, K. A. The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism. Eur. J. Pharm. Biopharm. 192, 126\u2013135 (2023).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"865_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39768-9","volume":"14","author":"K Liu","year":"2023","unstructured":"Liu, K. et al. Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function. Nat. Commun. 14, 4007 (2023).","journal-title":"Nat. Commun."},{"key":"865_CR144","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41565-021-01030-y","volume":"17","author":"MZC Hatit","year":"2022","unstructured":"Hatit, M. Z. C. et al. Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nat. Nanotechnol. 17, 310\u2013318 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR145","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1248\/bpb.b19-00743","volume":"43","author":"IA Khalil","year":"2020","unstructured":"Khalil, I. A., Younis, M. A., Kimura, S. & Harashima, H. Lipid nanoparticles for cell-specific in vivo targeted delivery of nucleic acids. Biol. Pharm. Bull. 43, 584\u2013595 (2020).","journal-title":"Biol. Pharm. Bull."},{"key":"865_CR146","doi-asserted-by":"publisher","first-page":"18150","DOI":"10.1021\/acsami.5c00920","volume":"17","author":"J Lee","year":"2025","unstructured":"Lee, J. et al. Chirality-controlled lipid nanoparticles for mRNA delivery. ACS Appl. Mater. Interfaces 17, 18150\u201318159 (2025).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"865_CR147","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41557-023-01138-9","volume":"15","author":"MZC Hatit","year":"2023","unstructured":"Hatit, M. Z. C. et al. Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery. Nat. Chem. 15, 508\u2013515 (2023).","journal-title":"Nat. Chem."},{"key":"865_CR148","doi-asserted-by":"publisher","first-page":"28595","DOI":"10.1021\/jacs.5c08345","volume":"147","author":"CK De","year":"2025","unstructured":"De, C. K. et al. The overlooked stereoisomers of the ionizable lipid ALC315. J. Am. Chem. Soc. 147, 28595\u201328600 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR149","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.xcrm.2025.102209","volume":"6","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z. et al. Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging. Cell Rep. Med. 6, 102209 (2025).","journal-title":"Cell Rep. Med."},{"key":"865_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32281-5","volume":"13","author":"H Ni","year":"2022","unstructured":"Ni, H. et al. Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo. Nat. Commun. 13, 4766 (2022).","journal-title":"Nat. Commun."},{"key":"865_CR151","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322935121","volume":"121","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Accelerating diabetic wound healing by ROS-scavenging lipid nanoparticle\u2013mRNA formulation. Proc. Natl Acad. Sci. USA 121, e2322935121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR152","doi-asserted-by":"publisher","first-page":"2204947","DOI":"10.1002\/adfm.202204947","volume":"32","author":"W Cai","year":"2022","unstructured":"Cai, W., Luo, T., Chen, X., Mao, L. & Wang, M. A combinatorial library of biodegradable lipid nanoparticles preferentially deliver mRNA into tumor cells to block mutant RAS signaling. Adv. Funct. Mater. 32, 2204947 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"865_CR153","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.1021\/acsnano.3c09028","volume":"18","author":"R Holland","year":"2024","unstructured":"Holland, R. et al. Silicon ether ionizable lipids enable potent mRNA lipid nanoparticles with rapid tissue clearance. ACS Nano 18, 10374\u201310387 (2024).","journal-title":"ACS Nano"},{"key":"865_CR154","doi-asserted-by":"publisher","first-page":"164285","DOI":"10.1016\/j.cej.2025.164285","volume":"516","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Incorporation of disulfide bonds into ionizable lipids enables efficient splenic mRNA delivery and potent immunotherapy in mice. Chem. Eng. J. 516, 164285 (2025).","journal-title":"Chem. Eng. J."},{"key":"865_CR155","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","volume":"19","author":"S Zhao","year":"2024","unstructured":"Zhao, S. et al. Acid-degradable lipid nanoparticles enhance the delivery of mRNA. Nat. Nanotechnol. 19, 1702\u20131711 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR156","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acs.bioconjchem.0c00295","volume":"31","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Combinatorial library of cyclic benzylidene acetal-containing pH-responsive lipidoid nanoparticles for intracellular mRNA delivery. Bioconjug. Chem. 31, 1835\u20131843 (2020).","journal-title":"Bioconjug. Chem."},{"key":"865_CR157","doi-asserted-by":"publisher","first-page":"2404684","DOI":"10.1002\/advs.202404684","volume":"11","author":"K Lv","year":"2024","unstructured":"Lv, K. et al. Discovery of ketal-ester ionizable lipid nanoparticle with reduced hepatotoxicity, enhanced spleen tropism for mRNA vaccine delivery. Adv. Sci. 11, 2404684 (2024).","journal-title":"Adv. Sci."},{"key":"865_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5277","volume":"5","author":"KA Whitehead","year":"2014","unstructured":"Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 4277 (2014).","journal-title":"Nat. Commun."},{"key":"865_CR159","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.actbio.2022.09.065","volume":"154","author":"P Patel","year":"2022","unstructured":"Patel, P. et al. Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery. Acta Biomater. 154, 374\u2013384 (2022).","journal-title":"Acta Biomater."},{"key":"865_CR160","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","volume":"21","author":"MA Maier","year":"2013","unstructured":"Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 21, 1570\u20131578 (2013).","journal-title":"Mol. Ther."},{"key":"865_CR161","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.nano.2015.03.006","volume":"11","author":"F Movahedi","year":"2015","unstructured":"Movahedi, F., Hu, R. G., Becker, D. L. & Xu, C. Stimuli-responsive liposomes for the delivery of nucleic acid therapeutics. Nanomed. Nanotechnol. Biol. Med. 11, 1575\u20131584 (2015).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"865_CR162","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202301102","volume":"135","author":"B Golba","year":"2023","unstructured":"Golba, B. et al. Visible light conjugation with triazolinediones as a route to degradable poly(ethylene glycol)\u2013lipids for mRNA lipid nanoparticle formulation. Angew. Chem. Int. Ed. 135, e202301102 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"865_CR163","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1021\/acsnano.2c10936","volume":"17","author":"Y Mo","year":"2023","unstructured":"Mo, Y. et al. Light-activated siRNA endosomal release (LASER) by porphyrin lipid nanoparticles. ACS Nano 17, 4688\u20134703 (2023).","journal-title":"ACS Nano"},{"key":"865_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42280-9","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Nanomechanical action opens endo-lysosomal compartments. Nat. Commun. 14, 6645 (2023).","journal-title":"Nat. Commun."},{"key":"865_CR165","first-page":"42221","volume":"147","author":"F Chen","year":"2025","unstructured":"Chen, F. et al. Ultrasound-activatable lipid nanoplatform for region-confined innate immune stimulation and mRNA vaccination therapy of cancer. J. Am. Chem. Soc. 147, 42221\u201342236 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR166","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005191118","volume":"118","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling. Proc. Natl Acad. Sci. USA 118, e2005191118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121570","volume":"286","author":"M Ripoll","year":"2022","unstructured":"Ripoll, M. et al. An imidazole modified lipid confers enhanced mRNA\u2013LNP stability and strong immunization properties in mice and non-human primates. Biomaterials 286, 121570 (2022).","journal-title":"Biomaterials"},{"key":"865_CR168","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","volume":"18","author":"X Han","year":"2023","unstructured":"Han, X. et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat. Nanotechnol. 18, 1105\u20131114 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR169","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41551-023-01082-6","volume":"9","author":"B Li","year":"2023","unstructured":"Li, B. et al. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nat. Biomed. Eng. 9, 167\u2013184 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"865_CR170","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/cbic.202000364","volume":"22","author":"G Moku","year":"2021","unstructured":"Moku, G., Vangala, S., Gulla, S. K. & Yakati, V. In vivo targeting of DNA vaccines to dendritic cells via the mannose receptor induces long-lasting immunity against melanoma. ChemBioChem 22, 523\u2013531 (2021).","journal-title":"ChemBioChem"},{"key":"865_CR171","doi-asserted-by":"publisher","first-page":"2303576","DOI":"10.1002\/advs.202303576","volume":"10","author":"R Das","year":"2023","unstructured":"Das, R. et al. Hybrid LNP prime dendritic cells for nucleotide delivery. Adv. Sci. 10, 2303576 (2023).","journal-title":"Adv. Sci."},{"key":"865_CR172","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jconrel.2020.06.027","volume":"325","author":"G Lou","year":"2020","unstructured":"Lou, G. et al. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: the impact of cationic lipid selection. J. Controlled Rel. 325, 370\u2013379 (2020).","journal-title":"J. Controlled Rel."},{"key":"865_CR173","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1021\/acsnano.2c12420","volume":"17","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Use of a liver-targeting immune-tolerogenic mRNA lipid nanoparticle platform to treat peanut-induced anaphylaxis by single- and multiple-epitope nucleotide sequence delivery. ACS Nano 17, 4942\u20134957 (2023).","journal-title":"ACS Nano"},{"key":"865_CR174","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","volume":"16","author":"Y Ju","year":"2022","unstructured":"Ju, Y. et al. Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano 16, 11769\u201311780 (2022).","journal-title":"ACS Nano"},{"key":"865_CR175","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41563-025-02240-8","volume":"24","author":"S Luozhong","year":"2025","unstructured":"Luozhong, S. et al. Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity. Nat. Mater. 24, 1852\u20131861 (2025).","journal-title":"Nat. Mater."},{"key":"865_CR176","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41563-024-02116-3","volume":"24","author":"Y Xiao","year":"2025","unstructured":"Xiao, Y. et al. High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics. Nat. Mater. 24, 1840\u20131851 (2025).","journal-title":"Nat. Mater."},{"key":"865_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42672-x","volume":"14","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Charge-altering releasable transporters enhance mRNA delivery in vitro and exhibit in vivo tropism. Nat. Commun. 14, 6983 (2023).","journal-title":"Nat. Commun."},{"key":"865_CR178","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1073\/pnas.1614193114","volume":"114","author":"CJ McKinlay","year":"2017","unstructured":"McKinlay, C. J. et al. Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals. Proc. Natl Acad. Sci. USA 114, E448\u2013E456 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR179","doi-asserted-by":"publisher","first-page":"E9153","DOI":"10.1073\/pnas.1810002115","volume":"115","author":"OAW Haabeth","year":"2018","unstructured":"Haabeth, O. A. W. et al. mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice. Proc. Natl Acad. Sci. USA 115, E9153\u2013E9161 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR180","doi-asserted-by":"publisher","first-page":"11679","DOI":"10.1021\/jacs.3c14010","volume":"146","author":"K Yang","year":"2024","unstructured":"Yang, K. et al. Biodegradable lipid-modified poly(guanidine thioctic acid)s: a fortifier of lipid nanoparticles to promote the efficacy and safety of mRNA cancer vaccines. J. Am. Chem. Soc. 146, 11679\u201311693 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26971","volume":"10","author":"R Deyhimfar","year":"2024","unstructured":"Deyhimfar, R. et al. The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases. Heliyon 10, e26971 (2024).","journal-title":"Heliyon"},{"key":"865_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.157098","volume":"198","author":"D Singh","year":"2026","unstructured":"Singh, D. Advances in lipid nanoparticle delivery systems for targeted cytokine immunotherapy in autoimmune disorders. Cytokine 198, 157098 (2026).","journal-title":"Cytokine"},{"key":"865_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31130-9","volume":"13","author":"S De Picciotto","year":"2022","unstructured":"De Picciotto, S. et al. Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein. Nat. Commun. 13, 3866 (2022).","journal-title":"Nat. Commun."},{"key":"865_CR184","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2174\/156652309788921044","volume":"9","author":"G Schulze-Tanzil","year":"2009","unstructured":"Schulze-Tanzil, G. et al. Interleukin-10 and articular cartilage: experimental therapeutical approaches in cartilage disorders. Curr. Gene Ther. 9, 306\u2013315 (2009).","journal-title":"Curr. Gene Ther."},{"key":"865_CR185","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/cells9030531","volume":"9","author":"I Raphael","year":"2020","unstructured":"Raphael, I., Joern, R. R. & Forsthuber, T. G. Memory CD4+ T cells in immunity and autoimmune diseases. Cells 9, 531 (2020).","journal-title":"Cells"},{"key":"865_CR186","doi-asserted-by":"publisher","first-page":"2005641","DOI":"10.1002\/adfm.202005641","volume":"31","author":"H Koide","year":"2021","unstructured":"Koide, H. et al. Engineering of lipid nanoparticles by the multifunctionalization of the surface with amino acid derivatives for the neutralization of a target toxic peptide. Adv. Funct. Mater. 31, 2005641 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"865_CR187","doi-asserted-by":"publisher","first-page":"34209","DOI":"10.1021\/jacs.4c14500","volume":"146","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. Crown-like biodegradable lipids enable lung-selective mRNA delivery and dual-modal tumor imaging in vivo. J. Am. Chem. Soc. 146, 34209\u201334220 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"865_CR188","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1073\/pnas.1620874114","volume":"114","author":"JE Dahlman","year":"2017","unstructured":"Dahlman, J. E. et al. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc. Natl Acad. Sci. USA 114, 2060\u20132065 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR189","doi-asserted-by":"publisher","first-page":"16151","DOI":"10.1021\/acsnano.4c01171","volume":"18","author":"AG Hamilton","year":"2024","unstructured":"Hamilton, A. G. et al. High-throughput in vivo screening identifies differential influences on mRNA lipid nanoparticle immune cell delivery by administration route. ACS Nano 18, 16151\u201316165 (2024).","journal-title":"ACS Nano"},{"key":"865_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45422-9","volume":"15","author":"L Xue","year":"2024","unstructured":"Xue, L. et al. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models. Nat. Commun. 15, 1884 (2024).","journal-title":"Nat. Commun."},{"key":"865_CR191","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41565-022-01146-9","volume":"17","author":"C Dobrowolski","year":"2022","unstructured":"Dobrowolski, C. et al. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery. Nat. Nanotechnol. 17, 871\u2013879 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR192","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41578-025-00831-0","volume":"11","author":"AR Hanna","year":"2025","unstructured":"Hanna, A. R., Issadore, D. A. & Mitchell, M. J. High-throughput platforms for machine learning-guided lipid nanoparticle design. Nat. Rev. Mater. 11, 50\u201364 (2025).","journal-title":"Nat. Rev. Mater."},{"key":"865_CR193","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","volume":"23","author":"B Li","year":"2024","unstructured":"Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002\u20131008 (2024).","journal-title":"Nat. Mater."},{"key":"865_CR194","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41565-025-01975-4","volume":"20","author":"A Chan","year":"2025","unstructured":"Chan, A. et al. Designing lipid nanoparticles using a transformer-based neural network. Nat. Nanotechnol. 20, 1491\u20131501 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR195","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","volume":"43","author":"J Witten","year":"2025","unstructured":"Witten, J. et al. Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nat. Biotechnol. 43, 1790\u20131799 (2025).","journal-title":"Nat. Biotechnol."},{"key":"865_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50619-z","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat. Commun. 15, 6305 (2024).","journal-title":"Nat. Commun."},{"key":"865_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55072-6","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery. Nat. Commun. 15, 10804 (2024).","journal-title":"Nat. Commun."},{"key":"865_CR198","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1021\/acsabm.4c01716","volume":"8","author":"G Kumar","year":"2025","unstructured":"Kumar, G. & Ardekani, A. M. Machine-learning framework to predict the performance of lipid nanoparticles for nucleic acid delivery. ACS Appl. Bio Mater. 8, 3717\u20133727 (2025).","journal-title":"ACS Appl. Bio Mater."},{"key":"865_CR199","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2217\/nnm-2020-0461","volume":"16","author":"PJ Harrison","year":"2021","unstructured":"Harrison, P. J. et al. Deep-learning dodels for lipid nanoparticle-based drug delivery. Nanomed 16, 1097\u20131110 (2021).","journal-title":"Nanomed"},{"key":"865_CR200","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.apsb.2021.11.021","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm. Acta Pharm. Sin. B 12, 2950\u20132962 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"865_CR201","doi-asserted-by":"publisher","first-page":"bbaf307","DOI":"10.1093\/bib\/bbaf307","volume":"26","author":"K Wu","year":"2025","unstructured":"Wu, K. et al. TransMA: an explainable multi-modal deep learning model for predicting properties of ionizable lipid nanoparticles in mRNA delivery. Brief. Bioinform. 26, bbaf307 (2025).","journal-title":"Brief. Bioinform."},{"key":"865_CR202","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae342","volume":"40","author":"S Moayedpour","year":"2024","unstructured":"Moayedpour, S. et al. Representations of lipid nanoparticles using large language models for transfection efficiency prediction. Bioinformatics 40, btae342 (2024).","journal-title":"Bioinformatics"},{"key":"865_CR203","doi-asserted-by":"publisher","first-page":"20672","DOI":"10.1021\/acsnano.5c01378","volume":"19","author":"K Cui","year":"2025","unstructured":"Cui, K. et al. Iterative screening of vitamin E-based functional lipid nanoparticles for mRNA delivery. ACS Nano 19, 20672\u201320692 (2025).","journal-title":"ACS Nano"},{"key":"865_CR204","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1021\/acs.nanolett.1c01353","volume":"21","author":"SJ Shepherd","year":"2021","unstructured":"Shepherd, S. J. et al. Scalable mRNA and siRNA lipid nanoparticle production using a parallelized microfluidic device. Nano Lett. 21, 5671\u20135680 (2021).","journal-title":"Nano Lett."},{"key":"865_CR205","doi-asserted-by":"publisher","first-page":"0370","DOI":"10.34133\/research.0370","volume":"7","author":"X Huang","year":"2024","unstructured":"Huang, X., Ma, Y., Ma, G. & Xia, Y. Unlocking the therapeutic applicability of LNP\u2013mRNA: chemistry, formulation, and clinical strategies. Research 7, 0370 (2024).","journal-title":"Research"},{"key":"865_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17409-9","volume":"11","author":"PF McKay","year":"2020","unstructured":"McKay, P. F. et al. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nat. Commun. 11, 3523 (2020).","journal-title":"Nat. Commun."},{"key":"865_CR207","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2505718122","volume":"122","author":"KL Swingle","year":"2025","unstructured":"Swingle, K. L. et al. Circular RNA lipid nanoparticle vaccine against SARS-CoV-2. Proc. Natl Acad. Sci. USA 122, e2505718122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR208","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"865_CR209","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/acs.bioconjchem.5c00282","volume":"36","author":"Y Kim","year":"2025","unstructured":"Kim, Y. et al. Mannose-conjugated cholesterol containing lipid nanoparticles for active targeted mRNA delivery to liver sinusoidal endothelial and kupffer cells. Bioconjug. Chem. 36, 2181\u20132196 (2025).","journal-title":"Bioconjug. Chem."},{"key":"865_CR210","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1021\/acs.molpharmaceut.2c00442","volume":"19","author":"LT Johnson","year":"2022","unstructured":"Johnson, L. T. et al. Lipid nanoparticle (LNP) chemistry can endow unique in vivo RNA delivery fates within the liver that alter therapeutic outcomes in a cancer model. Mol. Pharm. 19, 3973\u20133986 (2022).","journal-title":"Mol. Pharm."},{"key":"865_CR211","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202310395","volume":"62","author":"E \u00c1lvarez-Benedicto","year":"2023","unstructured":"\u00c1lvarez-Benedicto, E. et al. Spleen SORT LNP generated in situ CAR T cells extend survival in a mouse model of lymphoreplete B cell lymphoma. Angew. Chem. Int. Ed. 62, e202310395 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"865_CR212","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz, L. M. et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534, 396\u2013401 (2016).","journal-title":"Nature"},{"key":"865_CR213","doi-asserted-by":"publisher","first-page":"30860","DOI":"10.1021\/acsnano.5c05370","volume":"19","author":"A Vaidya","year":"2025","unstructured":"Vaidya, A. et al. Endogenous targeting of lipid nanoparticles to kidney tumors. ACS Nano 19, 30860\u201330871 (2025).","journal-title":"ACS Nano"},{"key":"865_CR214","doi-asserted-by":"publisher","first-page":"1902251","DOI":"10.1002\/adma.201902251","volume":"31","author":"MP Lokugamage","year":"2019","unstructured":"Lokugamage, M. P., Sago, C. D., Gan, Z., Krupczak, B. R. & Dahlman, J. E. Constrained nanoparticles deliver siRNA and sgRNA to T cells in vivo without targeting ligands. Adv. Mater. 31, 1902251 (2019).","journal-title":"Adv. Mater."},{"key":"865_CR215","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","volume":"20","author":"MZ Chen","year":"2025","unstructured":"Chen, M. Z. et al. A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles. Nat. Nanotechnol. 20, 1273\u20131284 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR216","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0022-2836(64)80115-7","volume":"8","author":"AD Bangham","year":"1964","unstructured":"Bangham, A. D. & Horne, R. W. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. 8, 660\u2013IN10 (1964).","journal-title":"J. Mol. Biol."},{"key":"865_CR217","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1021\/bi00705a003","volume":"13","author":"K Uemura","year":"1974","unstructured":"Uemura, K., Nicolotti, R. A., Six, H. R. & Kinsky, S. C. Antibody formation in response to liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives. Biochemistry 13, 1572\u20131578 (1974).","journal-title":"Biochemistry"},{"key":"865_CR218","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0304-4157(79)90012-1","volume":"559","author":"PR Cullis","year":"1979","unstructured":"Cullis, P. R. & De Kruijff, B. Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim. Biophys. Acta BBA 559, 399\u2013420 (1979).","journal-title":"Biochim. Biophys. Acta BBA"},{"key":"865_CR219","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.98.1.139","volume":"98","author":"MC Kielian","year":"1984","unstructured":"Kielian, M. C., Ker\u00e4nen, S., K\u00e4\u00e4ri\u00e4inen, L. & Helenius, A. Membrane fusion mutants of Semliki Forest virus. J. Cell Biol. 98, 139\u2013145 (1984).","journal-title":"J. Cell Biol."},{"key":"865_CR220","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","volume":"84","author":"PL Felgner","year":"1987","unstructured":"Felgner, P. L. et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84, 7413\u20137417 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR221","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed. 51, 8529\u20138533 (2012).","journal-title":"Angew. Chem. Int. Ed."},{"key":"865_CR222","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2014.84","volume":"9","author":"JE Dahlman","year":"2014","unstructured":"Dahlman, J. E. et al. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat. Nanotechnol. 9, 648\u2013655 (2014).","journal-title":"Nat. Nanotechnol."},{"key":"865_CR223","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/adma.201505822","volume":"28","author":"OS Fenton","year":"2016","unstructured":"Fenton, O. S. et al. Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery. Adv. Mater. 28, 2939\u20132943 (2016).","journal-title":"Adv. Mater."},{"key":"865_CR224","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00751-6","volume":"8","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Effect of mRNA\u2013LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability. npj Vaccines 8, 156 (2023).","journal-title":"npj Vaccines"},{"key":"865_CR225","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0022-2836(61)80072-7","volume":"3","author":"F Jacob","year":"1961","unstructured":"Jacob, F. & Monod, J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3, 318\u2013356 (1961).","journal-title":"J. Mol. Biol."},{"key":"865_CR226","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0006-291X(69)90720-7","volume":"37","author":"RE Lockard","year":"1969","unstructured":"Lockard, R. E. & Lingrel, J. B. The synthesis of mouse hemoglobin chains in a rabbit reticulocyte cell-free system programmed with mouse reticulocyte 9S RNA. Biochem. Biophys. Res. Commun. 37, 204\u2013212 (1969).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"865_CR227","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1073\/pnas.80.4.1068","volume":"80","author":"C Nicolau","year":"1983","unstructured":"Nicolau, C., Le Pape, A., Soriano, P., Fargette, F. & Juhel, M. F. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc. Natl Acad. Sci. USA 80, 1068\u20131072 (1983).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR228","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff, J. A. et al. Direct gene transfer into mouse muscle in vivo. Science 247, 1465\u20131468 (1990).","journal-title":"Science"},{"key":"865_CR229","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1546298","volume":"255","author":"GF Jirikowski","year":"1992","unstructured":"Jirikowski, G. F., Sanna, P. P., Maciejewski-Lenoir, D. & Bloom, F. E. Reversal of diabetes insipidus in brattleboro rats: intrahypothalamic injection of vasopressin mRNA. Science 255, 996\u2013998 (1992).","journal-title":"Science"},{"key":"865_CR230","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/eji.1830230749","volume":"23","author":"F Martinon","year":"1993","unstructured":"Martinon, F. et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 23, 1719\u20131722 (1993).","journal-title":"Eur. J. Immunol."},{"key":"865_CR231","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz, Y. Doxil \u2014 the first FDA-approved nano-drug: lessons learned. J. Controlled Rel. 160, 117\u2013134 (2012).","journal-title":"J. Controlled Rel."},{"key":"865_CR232","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1084\/jem.184.2.465","volume":"184","author":"D Boczkowski","year":"1996","unstructured":"Boczkowski, D., Nair, S. K., Snyder, D. & Gilboa, E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465\u2013472 (1996).","journal-title":"J. Exp. Med."},{"key":"865_CR233","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1515\/BC.2001.065","volume":"382","author":"N Meidenbauer","year":"2001","unstructured":"Meidenbauer, N., Andreesen, R. & Mackensen, A. Dendritic cells for specific cancer immunotherapy. Biol. Chem. 382, 507\u2013520 (2001).","journal-title":"Biol. Chem."},{"key":"865_CR234","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165\u2013175 (2005).","journal-title":"Immunity"},{"key":"865_CR235","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature04688","volume":"441","author":"TS Zimmermann","year":"2006","unstructured":"Zimmermann, T. S. et al. RNAi-mediated gene silencing in non-human primates. Nature 441, 111\u2013114 (2006).","journal-title":"Nature"},{"key":"865_CR236","doi-asserted-by":"publisher","first-page":"14604","DOI":"10.1073\/pnas.1209367109","volume":"109","author":"AJ Geall","year":"2012","unstructured":"Geall, A. J. et al. Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl Acad. Sci. USA 109, 14604\u201314609 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"865_CR237","doi-asserted-by":"publisher","first-page":"17","DOI":"10.32607\/actanaturae.27707","volume":"17","author":"AA Ibragimova","year":"2025","unstructured":"Ibragimova, A. A. et al. mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes. Acta Naturae 17, 17\u201337 (2025).","journal-title":"Acta Naturae"},{"key":"865_CR238","doi-asserted-by":"publisher","first-page":"102859","DOI":"10.1016\/j.omtn.2026.102859","volume":"37","author":"C Chakraborty","year":"2026","unstructured":"Chakraborty, C., Bhattacharya, M., Das, A., Agoramoorthy, G. & Lee, S.-S. CRISPR\u2013Cas9-mediated therapeutics: current clinical trials and therapy approval landscape to treat human diseases. Mol. Ther. Nucleic Acids 37, 102859 (2026).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"865_CR239","doi-asserted-by":"publisher","first-page":"102666","DOI":"10.1016\/j.omtn.2025.102666","volume":"36","author":"M Raigani","year":"2025","unstructured":"Raigani, M., Eftekhari, Z., Adeli, A. & Kazemi-Lomedasht, F. Advancing gene editing therapeutics: clinical trials and innovative delivery systems across diverse diseases. Mol. Ther. Nucleic Acids 36, 102666 (2025).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"865_CR240","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","volume":"153","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering. Cell 153, 910\u2013918 (2013).","journal-title":"Cell"}],"container-title":["Nature Reviews Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00865-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:02:03Z","timestamp":1791288123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00865-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":240,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1038\/s41570-026-00865-0","relation":{},"ISSN":["2397-3358"],"issn-type":[{"value":"2397-3358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"9 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J.M. is named on patents describing the use of LNPs and lipid compositions for nucleic acid delivery that are discussed in this Review. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}